[1]
« Clinical and laboratory predictors of therapeutic response to Tocilizumab in rheumatoid arthritis », OH&RM, vol. 6, nᵒ 3, p. 44–53, sept. 2025, doi: 10.38045/ohrm.2025.3.04.